EX-FILING FEES 11 d383050dexfilingfees.htm EX-FILING FEES

Exhibit 107

Calculation of Filing Fee Tables

Form S-1

(Form Type)

Acrivon Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

|  | Security Type |  | Security Class Title |  | Fee Calculation or Carry Forward Rule |  | Amount Registered |  | Proposed Maximum Offering Price Per Unit |  | Maximum Aggregate Offering Price(1) |  | Fee Rate |  | Amount of Registration Fee(2)
Fees to Be Paid |  | Equity |  | Common Stock, par value $0.001 per share |  | 457(a) |  | 6,785,000 |  | $18.00 |  | $122,130,000 |  | 0.00011020 |  | $13,459
|  | Total Offering Amounts |  |  |  |  |  | — |  | $13,459
|  | Total Fees Previously Paid |  |  |  | — |  | — |  | $11,020
|  | Total Fee Offsets |  |  |  | — |  | — |  | —
|  | Net Fee Due |  |  |  | — |  | — |  | $2,439

(1) | Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(a) under the Securities Act of 1933, as amended (the “Securities Act”). Includes the aggregate offering price of 885,000 additional shares that the underwriters have the option to purchase.

(2) | Calculated pursuant to Rule 457(a) under the Securities Act based on an estimate of the proposed maximum aggregate offering price.